Our interventional cardiology faculty lead clinical research to develop and evaluate new structural, complex coronary and endovascular interventions.
With funding from the National Institutes of Health, the Centers for Medicare & Medicaid Services and industry collaborations, our faculty are international and site principal investigators on several single- and multi-center FDA Phase 1, 2 and 3 drug and device trials.
